Gail Maderis is a biotechnology executive with extensive experience leading both private and public companies as well as non-profits. Currently, Maderis serves as Chair of the Board of Directors at TMAB Therapeutics, Inc., and holds multiple board positions, including with Valitor, Inc. and Antiva Biosciences, Inc. Previously, Maderis was President & CEO at Five Prime Therapeutics and held various leadership roles at Genzyme Corporation. Maderis is also a trustee at the UC Berkeley Foundation and has a robust network in the life sciences sector focused on entrepreneurship and patient treatment advancements.
This person is not in the org chart
This person is not in any teams
This person is not in any offices